A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia.
about
Dietary interventions (plant sterols, stanols, omega-3 fatty acids, soy protein and dietary fibers) for familial hypercholesterolaemiaClinical management of children and young adults with heterozygous familial hypercholesterolaemia in the UKCardiovascular risk stratification in familial hypercholesterolaemiaNew developments in atherosclerosis: clinical potential of PCSK9 inhibitionFamilial hypercholesterolemia: an under-recognized but significant concern in cardiology practiceImproving the cost-effectiveness equation of cascade testing for familial hypercholesterolaemiaFamilial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis SocietyUse of targeted exome sequencing as a diagnostic tool for Familial HypercholesterolaemiaPCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease.LDL-Cholesterol: Standards of Treatment 2016: A German Perspective.Novel and recurrent LDLR gene mutations in Pakistani hypercholesterolemia patients.Molecular prediction for atherogenic risks across different cell types of leukocytes.Low-density lipoprotein receptor gene familial hypercholesterolemia variant database: update and pathological assessment.The UK Paediatric Familial Hypercholesterolaemia Register: preliminary dataPatient accounts of diagnostic testing for familial hypercholesterolaemia: comparing responses to genetic and non-genetic testing methods.US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry.The D9N, N291S and S447X variants in the lipoprotein lipase (LPL) gene are not associated with Type III hyperlipidemia.Genomic characterization of large rearrangements of the LDLR gene in Czech patients with familial hypercholesterolemiaCholesterol and benign prostate disease.Use of atorvastatin in systemic lupus erythematosus in children and adolescentsWhole exome sequencing of familial hypercholesterolaemia patients negative for LDLR/APOB/PCSK9 mutationsFamilial hypercholesterolemia: developments in diagnosis and treatmentFamilial hypercholesterolaemia in South Africans: tracking findings and developments over time - with reference to : prevalence of hypercholesterolaemia in young Afrikaners with myocardial infarction. Ischaemic heart disease risk factors.LDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectivesHeterozygous familial hypercholesterolemia: an underrecognized cause of early cardiovascular disease.Perceived vulnerability to heart disease in patients with familial hypercholesterolemia: a qualitative interview study.Long-term statin treatment in children with familial hypercholesterolemia: more insight into tolerability and adherence.Would raising the total cholesterol diagnostic cut-off from 7.5 mmol/L to 9.3 mmol/L improve detection rate of patients with monogenic familial hypercholesterolaemia?Systematic cell-based phenotyping of missense alleles empowers rare variant association studies: a case for LDLR and myocardial infarction.Genetic testing of Korean familial hypercholesterolemia using whole-exome sequencing.Familial hypercholesterolaemia commonly presents with Achilles tenosynovitisGenetically defined hyperlipidemia.A model of care for familial hypercholesterolaemia: key role for clinical biochemistry.Recommendations for lipid testing and reporting by Australian pathology laboratories.Low-density lipoprotein apheresis: an evidence-based analysisHow do patients at risk portray candidates for coronary heart disease? A qualitative interview studyPharmacoeconomics of PCSK9 inhibitors in 103 hypercholesterolemic patients referred for diagnosis and treatment to a cholesterol treatment center.Systematic analysis of variants related to familial hypercholesterolemia in families with premature myocardial infarctionPremature cardiovascular disease in young women with heterozygous familial hypercholesterolemia.Successful Direct Adsorption of Lipoproteins (DALI) Apheresis During Pregnancy in an Omani Woman with Homozygous Familial Hypercholesterolemia.
P2860
Q24194060-DDB88B53-BA46-4CC2-AC5B-E9414E1B8AA9Q24522271-A1EF485B-EACA-4BD7-9E67-1BF88ECCF748Q26749104-DA06B095-F5E3-46B8-8590-77F20DAD29C5Q26783407-2CBA0188-019F-4A14-92D3-9E94B2846DA0Q26828401-A5954458-5807-4519-9DDD-6D0F3743A513Q26828780-59289388-E6DA-4C10-B223-418CAF1A0F51Q27024882-E3E626A1-434D-485D-B0B1-9DE576C70A72Q28716905-B6D8CB8B-242B-4E8B-B688-587CB746A7C8Q30234612-64E2007B-504A-47B5-912B-1DB42AB57EDEQ30248925-D3DA90F9-2F9A-4A63-AD6E-EB89E2D74E0EQ30412645-4EF58D4A-06F5-46E1-B8F7-09D5A110B100Q30428425-279B829B-5763-4DD7-895F-06D79588AFE0Q30485634-ED8C8CAB-DA24-4ADF-AA50-F01BA66929B2Q31053814-69A27A78-451D-471F-A99D-E268B820ADC2Q31096111-759D4C50-0B46-4E80-A21F-4840A23D0A32Q31133478-61D6E928-9823-4932-A07F-266C1A20D4B8Q33295440-C862DF74-D6C4-45A6-9BC4-177019AB294CQ33642312-2C53239F-3BE1-4494-A17D-C51565D32EF9Q33732687-38E18566-19B5-4ACF-BA95-E4BC0DD4A7A5Q33818710-44090770-2FB6-42E0-80CD-3BC50484D614Q33956413-DBE6E2B5-E556-4EB3-BB99-54D6F5808DB8Q34106665-1D470F34-6B54-430F-861D-51314BD3895BQ34365982-EC37FB60-7530-4047-8EA8-79005A36F20BQ34467839-D59BFE78-3889-4AA5-A0BF-FF25A9752182Q34499298-57C4F803-CC2D-4D65-AB85-A1E6C5600EBDQ34682202-4F005A13-BE88-4EC5-B6C4-ACC1C5153B6BQ35214678-79476310-4C00-4315-B3EA-9865436738F4Q35217153-EC7E68B2-7CF2-4EF9-9078-1253ABBAE680Q35538234-F036F4C0-2D30-4E76-8BD1-F044B9F44CDFQ35592865-81058B79-9157-425C-B078-96BDB94BD899Q35636858-DCC2D228-CCE3-420D-B584-5BD8A114E8E4Q35753332-6B1E6411-5B81-472B-A7E0-0409FD182981Q35771729-46D3118A-5136-495D-943B-8DAE2DBEB638Q35865522-010A5232-B571-46A7-8EA1-AE58597666C2Q36040181-CB526243-439F-4F81-85E8-9EC6508A0BBBQ36047862-C91FD1CE-4C35-41AD-89D8-F8005C95BE11Q36107244-BF8D834D-1069-4B44-B480-C34302C80008Q36474966-C3B4E211-95C1-4F8B-BD71-358B49AFEF79Q36484907-CA6410BE-8F40-4AB3-AF4F-141F70518EECQ36622909-CB63905A-8527-4AAC-85A7-FD6A170B4118
P2860
A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
A review on the diagnosis, nat ...... amilial hypercholesterolaemia.
@ast
A review on the diagnosis, nat ...... amilial hypercholesterolaemia.
@en
type
label
A review on the diagnosis, nat ...... amilial hypercholesterolaemia.
@ast
A review on the diagnosis, nat ...... amilial hypercholesterolaemia.
@en
prefLabel
A review on the diagnosis, nat ...... amilial hypercholesterolaemia.
@ast
A review on the diagnosis, nat ...... amilial hypercholesterolaemia.
@en
P2093
P1433
P1476
A review on the diagnosis, nat ...... amilial hypercholesterolaemia.
@en
P2093
Dalya Marks
H Andrew W Neil
Steve E Humphries
P356
10.1016/S0021-9150(02)00330-1
P577
2003-05-01T00:00:00Z